Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu(Howard Hughes Medical Institute), Daniel A. Haber(Howard Hughes Medical Institute), Marissa W. Madden(Harvard University), Petar Stojanov(Broad Institute), David T. Ting(Massachusetts General Hospital), Francesca Bersani(Ospedale San Luigi Gonzaga), Zongli Zheng(City University of Hong Kong), Ravi Kapur(Harvard University), Dennis C. Sgroi(Massachusetts General Hospital), Aditya Bardia(UCLA Health), Maria Donaldson Collier(The Netherlands Cancer Institute), A. John Iafrate(Massachusetts General Hospital), Cyril H. Benes(Harvard University), Elena F. Brachtel(University of Miami Hospital), Ben S. Wittner(Broad Institute), Shyamala Maheswaran(Massachusetts General Hospital), Mehmet Toner(Center for Cancer Research), Nicola Aceto(ETH Zurich), Valentine Comaills(Harvard University), Huili Zhu(Yantai University), Rushil Desai(Harvard University), Gad Getz(Broad Institute), Sridhar Ramaswamy(Harvard University), Toshi Shioda(Center for Cancer Research)
Cited by 911
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k